版权说明：本文档由用户提供并上传，收益归属内容提供方，若内容存在侵权，请进行举报或认领
文档简介
TheEPShow
COMPANIONandCARE-HFEricPrystowskyMD Director,ClinicalElectrophysiologyLaboratory StVincentHospital Indianapolis,IN
HughCalkinsMD Director,ElectrophysiologyLab JohnsHopkinsUniversityMedicalCenter Baltimore,MDJohnClelandMD ProfessorofCardiology HullUniversity KingstonuponHull,UK
TheEPShow
COMPANIONandCARE
Useofcardiacresynchronizationtherapy(CRT)inCOMPANION
andCARE-HF
UseofcardiacresynchronizatBriefhistoryLargegroupofpatientsinneedofICDsforprimarypreventionNeweraofbiventricularpacingtoimproveHFsymptomsCOMPANIONandCARE-HFBriefhistoryLargegroupofp
ComparisonofMedicalTherapy,Pacing,andDefibrillationinHeartFailure
COMPANION
ComparisonofMedicalTherapCOMPANIONDesignParallel,randomizedclinicaltrialin1600patientswithmoderateorsevereheartfailurewithQRS>120msandPRinterval>150ms(BristowMRetal.NEnglJMed2004;350:2140-2150)Patientsrandomizedina1:2:2fashiontooptimalmedicaltherapy;optimaldrugtherapyplusCRT;oroptimaldrugtherapyplusCRTwithanICD(CRT-D)COMPANIONDesignResultsPrimaryendpointCombinationofall-causedeathandall-causehospitalizationsreduced19%intheCRTstudyarmand20%intheCRT-DstudyarmDeathfromorhospitalizationforHFreduced34%inCRTgroupand40%inCRT-DgroupResultsPrimaryendpointResultsSecondaryendpointCRTaloneassociatedwithanonsignificanttrendtowarda24%reductioninall-causemortality,asecondaryendpointofthestudyCRTwithadefibrillatorreducedall-causemortality36%,ahighlysignificantresultResultsSecondaryendpointSignificantreductions"Thisstudyshowedinalargepopulationofpatientsthatresynchronizationtherapyimprovessurvivalandreduceshospitalization."Survivalbenefitlimitedto
thosewithCRTandICDCalkinsSignificantreductions"ThisstCRTchallengesImplantingthecoronarysinusleadDifficultyinvolvesnotgettingtheleadin,butgettingitintherightplaceToachieveeffectiveresynchronization,theleadneedstobeimplantedinalateralbranchofthecoronarysinusRequiresexperiencedimplanterCRTchallengesImplantingthec
Cardiac
Resynchronization
HeartFailure
CARE-HF
CardiacResynchronization
HeCARE-HFRationaleCardiacdyssynchronyaprobleminalargenumberofpatientswithHFandleftventricularsystolicdysfunctionPreviousstudieshavesuggestedthatCRTcanimprovesymptoms,qualityoflife,andexercisecapacityNoconclusiveevidenceofaneffectonhospitalizationsormortality
CARE-HFRationaleCARE-HFDesignRandomized,controlled,open-label,blinded-end-pointstudyRandomizedpatientstocontinuewithmedicaltherapyortoreceiveCRTIncluded813patientswithNYHAclass3-4HFdespitestandarddrugtherapy,anLVEF<35%,andQRSdurationofatleast120msCARE-HFDesignCARE-HFPatientswithaQRSduration<150mswererequiredtohaveechocardiographicconfirmationofventriculardyssynchronyPrimaryendpointwasall-causemortality/unplannedhospitalizationforCVeventCARE-HFPatientswithaQRSdurStrengthsofCARE-HFStudydetailsLargecontrolgroupImplantsuccessrate96%Long-termfollow-up,withanaverageof2.5yearsAverageageofpatient67yearsOnly40%ofpatientstaking>80mgfurosemide(mostcommondosewas40mgdaily)StrengthsofCARE-HFStudydetaClelandJGFetal.NEnglJMed2005;352:1539-1549Primaryandsecondaryoutcomesin
CARE-HFOutcomesHazardratio(95%CI)pAll-causemortality/unplannedhospitalizationforCVevent
0.63(0.51-0.77)
<0.0001All-causemortality0.64(0.48-0.85)0.0019All-causemortality/HFhospitalization0.54(0.43-0.68)<0.0001ClelandJGFetal.NEnglJMeOtherimprovementsCRTgroupalsobenefitedsignificantlywithimprovedLVEF,NYHAclass,end-systolicvolume,mitral-valvefunction,bloodpressure,andquality-of-lifeindices
Dramaticimprovementsat18monthsinlevelsofN-terminalpro-B-typenatriureticpeptide(NT-proBNP)OtherimprovementsCRTgroupalProblemsencounteredLeadproblems27lead-relatedproblems,suchasfractureordisplacement,inthe409patientsrandomizedtoCRTNumberofcasesofcoronarysinusdissection,noneofwhichcauseddeathOneprocedure-relateddeathineachgroupProblemsencounteredLeadproblPossibleremission"Ithinkweseeasubstantialproportionofpatientswhobecomeasymptomaticandwhosecardiacfunctionisnormalizedbythistherapy."
PossibilityofHF"remission"
ClelandPossibleremission"IthinkweWhattherapy?NoquestiontothevalueofCRT,butcandidatesforCRTarealsocandidatesforICDtherapyThequestionthenbecomes,whichtreatmentdotheyreceive?Whattherapy?NoquestiontothTreatingpatients"It'safairlyeasydecision."Realdifferencecomesdowntocost,
buttheaddedprotectionofthe
ICDwarrantstheuseofCRT
withadefibrillatorCalkinsTreatingpatients"It'safairlOtherissuesMorbidityThereisthepossibilityofinappropriateshocksfromtheICDinhealthypatientswhomightnotstandtobenefitfromitsadditionInstudiesusingolderdevices,themorbidityfromthedefibrillatorwasunacceptableOtherissuesMorbidityIfmoneywerenotanissue...CRTwithnewerdefibrillatorsdoesprovideanadditionalbenefitButcostintheUKremainsan
issue,andIwouldcontinuetobe
selectiveaboutwhichpatients
receivedCRTwithdefibrillator
backupClelandIfmoneywerenotanissue..Patientselection
HaveyoulearnedanythingfromthestudiesthatwouldhelpyouselectpatientsforaCRT-Dimplant? -Prystowsky
Thebriefanswertothatisnotyet. -ClelandPatientselection
HaveyouleaInappropriateshocksNotacaseofinappropriateshocksbutinappropriateprogrammers
EPsprogrammingdevicesthatdeliverinappropriateshocksmorethan5%ofthetimeneedtogobacktoschoolPrystowskyInappropriateshocksNotacaseInappropriateshocks"Itirksmeattimesbecausepeoplethrowthatupasareasonnottogetadefibrillator,butIsaygetabetterimplanter,getasmarterdoctor." -Prystowsky"Butnoteverybodycancometoyourcenterandbenefitfromyourexpertise." -ClelandInappropriateshocks"ItirksmLookingtothefutureInterestingissueasnoteverybodywithawideQRSbenefits,andevensomewithanarrowQRSbenefitfromCRTPathophysiologysuggestsapplyingtherapyearlier,topatientsinNYHAclass2,topreventprogressionofHFLookingtothefutureInterestiLookingtothefuture"ThefactthatCARE-HFwassopositiveinarathermilderpopulationthanCOMPANIONsupportsthedrifttousingthesedevicesatanearlierstage."ClelandLookingtothefutureClelandPatientselectionSomepatientshavesuchdramaticimprovementswithCRTthattheymaynolongerbecandidatesforanICD
NeedmoreresearchonthebenefitofthedefibrillatorinCRT-DtherapyPatientselectionSomepatientsConclusionsSummaryPatientwhomeetscriteriaforresynchronizationshouldbetreatedaccordinglyDefibrillatorcomponentremainstobedebated,mainlyduetotheissueofeconomicsConclusionsSummaryConclusionsCARE-HFshowedmajorreductionsinmortalitywithpacingalone"Theworldisbetteroffforthefactthatwe'vehadthesetwostudies." -PrystowskyConclusionsCARE-HFshowedmajoTheEPShow
COMPANIONandCARE-HFEricPrystowskyMD Director,ClinicalElectrophysiologyLaboratory StVincentHospital Indianapolis,IN
HughCalkinsMD Director,ElectrophysiologyLab JohnsHopkinsUniversityMedicalCenter Baltimore,MDJohnClelandMD ProfessorofCardiology HullUniversity KingstonuponHull,UK
TheEPShow
COMPANIONandCARE
Useofcardiacresynchronizationtherapy(CRT)inCOMPANION
andCARE-HF
UseofcardiacresynchronizatBriefhistoryLargegroupofpatientsinneedofICDsforprimarypreventionNeweraofbiventricularpacingtoimproveHFsymptomsCOMPANIONandCARE-HFBriefhistoryLargegroupofp
ComparisonofMedicalTherapy,Pacing,andDefibrillationinHeartFailure
COMPANION
ComparisonofMedicalTherapCOMPANIONDesignParallel,randomizedclinicaltrialin1600patientswithmoderateorsevereheartfailurewithQRS>120msandPRinterval>150ms(BristowMRetal.NEnglJMed2004;350:2140-2150)Patientsrandomizedina1:2:2fashiontooptimalmedicaltherapy;optimaldrugtherapyplusCRT;oroptimaldrugtherapyplusCRTwithanICD(CRT-D)COMPANIONDesignResultsPrimaryendpointCombinationofall-causedeathandall-causehospitalizationsreduced19%intheCRTstudyarmand20%intheCRT-DstudyarmDeathfromorhospitalizationforHFreduced34%inCRTgroupand40%inCRT-DgroupResultsPrimaryendpointResultsSecondaryendpointCRTaloneassociatedwithanonsignificanttrendtowarda24%reductioninall-causemortality,asecondaryendpointofthestudyCRTwithadefibrillatorreducedall-causemortality36%,ahighlysignificantresultResultsSecondaryendpointSignificantreductions"Thisstudyshowedinalargepopulationofpatientsthatresynchronizationtherapyimprovessurvivalandreduceshospitalization."Survivalbenefitlimitedto
thosewithCRTandICDCalkinsSignificantreductions"ThisstCRTchallengesImplantingthecoronarysinusleadDifficultyinvolvesnotgettingtheleadin,butgettingitintherightplaceToachieveeffectiveresynchronization,theleadneedstobeimplantedinalateralbranchofthecoronarysinusRequiresexperiencedimplanterCRTchallengesImplantingthec
Cardiac
Resynchronization
HeartFailure
CARE-HF
CardiacResynchronization
HeCARE-HFRationaleCardiacdyssynchronyaprobleminalargenumberofpatientswithHFandleftventricularsystolicdysfunctionPreviousstudieshavesuggestedthatCRTcanimprovesymptoms,qualityoflife,andexercisecapacityNoconclusiveevidenceofaneffectonhospitalizationsormortality
CARE-HFRationaleCARE-HFDesignRandomized,controlled,open-label,blinded-end-pointstudyRandomizedpatientstocontinuewithmedicaltherapyortoreceiveCRTIncluded813patientswithNYHAclass3-4HFdespitestandarddrugtherapy,anLVEF<35%,andQRSdurationofatleast120msCARE-HFDesignCARE-HFPatientswithaQRSduration<150mswererequiredtohaveechocardiographicconfirmationofventriculardyssynchronyPrimaryendpointwasall-causemortality/unplannedhospitalizationforCVeventCARE-HFPatientswithaQRSdurStrengthsofCARE-HFStudydetailsLargecontrolgroupImplantsuccessrate96%Long-termfollow-up,withanaverageof2.5yearsAverageageofpatient67yearsOnly40%ofpatientstaking>80mgfurosemide(mostcommondosewas40mgdaily)StrengthsofCARE-HFStudydetaClelandJGFetal.NEnglJMed2005;352:1539-1549Primaryandsecondaryoutcomesin
CARE-HFOutcomesHazardratio(95%CI)pAll-causemortality/unplannedhospitalizationforCVevent
0.63(0.51-0.77)
<0.0001All-causemortality0.64(0.48-0.85)0.0019All-causemortality/HFhospitalization0.54(0.43-0.68)<0.0001ClelandJGFetal.NEnglJMeOtherimprovementsCRTgroupalsobenefitedsignificantlywithimprovedLVEF,NYHAclass,end-systolicvolume,mitral-valvefunction,bloodpressure,andquality-of-lifeindices
Dramaticimprovementsat18monthsinlevelsofN-terminalpro-B-typenatriureticpeptide(NT-proBNP)OtherimprovementsCRTgroupalProblemsencounteredLeadproblems27lead-relatedproblems,suchasfractureordisplacement,inthe409patientsrandomizedtoCRTNumberofcasesofcoronarysinusdissection,noneofwhichcauseddeathOneprocedure-relateddeathineachgroupProblemsencounteredLeadproblPossibleremission"Ithinkweseeasubstantialproportionofpatientswhobecomeasymptomaticandwhosecardiacfunctionisnormalizedbythistherapy."
PossibilityofHF"remission"
ClelandPossibleremission"IthinkweWhattherapy?NoquestiontothevalueofCRT,butcandidatesforCRTarealsocandidatesforICDtherapyThequestionthenbecomes,whichtreatmentdotheyreceive?Whattherapy?NoquestiontothTreatingpatients"It'safairlyeasydecision."Realdifferencecomesdowntocost,
buttheaddedprotectionofthe
ICDwarrantstheuseofCRT
withadefibrillatorCalkinsTreatingpatients"It'safairlOtherissuesMorbidityThereisthepossibilityofinappropriateshocksfromtheICDinhealthypatientswhomightnotstandtobenefitfromitsadditionInstudiesusingolderdevices,themorbidityfromthedefibrillatorwasunacceptableOtherissuesMorbidityIfmoneywerenotanissue...CRTwithnewerdefibrillatorsdoesprovideanadditionalbenefitButcostintheUKremainsan
issue,andIwouldcontinuetobe
selectiveaboutwhichpatients
receivedCRTwithdefibrillator
backupClelandIfmoneywerenotanissue..Patientselection
HaveyoulearnedanythingfromthestudiesthatwouldhelpyouselectpatientsforaCRT-Dimplant? -Prystowsky
Thebriefanswertothatisnotyet. -ClelandPatientselection
HaveyouleaInappropriateshocksNotacaseofinappropriateshocksbutinappropriateprogrammers
EPsprogrammingdevicesthatdeliverinappropriateshocksmorethan5%ofthetime
温馨提示
- 1. 本站所有资源如无特殊说明，都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等，如果需要附件，请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸，网页内容里面会有图纸预览，若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间，仅对用户上传内容的表现方式做保护处理，对用户上传分享的文档内容本身不做任何修改或编辑，并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容，请与我们联系，我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 五年级下册数学教案-4.1 容积｜北师大版
- 2025年机动车典当合同
- 六年级上册数学教案-总复习 你会算吗-求阴影部分的面积｜北师大版
- 2025年科研合作协议
- 第四单元骄人祖先 灿烂文化整体教学设计-2024-2025学年道德与法治五年级上册统编版
- Unit 3 I'm more outgoing than my sister. SectionB 1a-1e教学设计2024-2025学年人教版英语八年级上册
- 2025年湖北三峡职业技术学院单招职业适应性测试题库汇编
- 2024年全脑开发项目资金申请报告代可行性研究报告
- 2025年嘉兴南洋职业技术学院单招职业技能测试题库完整
- 2025年共青科技职业学院单招职业适应性测试题库完整版
- 高二数学（含创意快闪特效）-【开学第一课】2023年高中秋季开学指南之爱上数学课
- 《学前儿童社会教育》学前儿童社会教育概述-pp课件
- 全国医学英语统考医学英语词汇表
- 【品牌建设研究国内外文献综述5000字】
- 国家电网公司电力安全工作规程(电力通信部分)(试行)
- 第八版-精神分裂症及其他精神病性障碍(中文)
- 小学一年级新生报名登记表
- 生态毒理学第三章毒物的分子效应与毒理学机制
- 智能财务共享在京东的应用研究
- 卫生和微生物基础知识培训-
- 2023年镇江市高等专科学校单招综合素质题库及答案解析
评论
0/150
提交评论